Speaking on the Union Budget 2026-27, Indian Council of Medical Research (ICMR) Director General Rajiv Bahl noted that the government has initiated a significant push to transform the country's pharmaceutical landscape by addressing regulatory gaps and enhancing research infrastructure. S
India's contract research, development, and manufacturing organisation (CRDMO) sector is emerging as one of the most dynamic growth stories in the global pharmaceutical landscape. According to a recent Jefferies India report, the country's CRDMO, which has already reached revenues of around
Ahmedabad (Gujarat) [India], August 5: India's pharmaceutical landscape is undergoing a vital transformation. Despite being home to one of the world's largest medicine markets, millions of Indian families continue to struggle with the high cost of treatment. Studies show that over 50% of hea
In recent order announced by the US President Donald Trump which aims to slash prescriptive drug prices in the United States to be lowered by up to 80 per cent, is likely to create ripple effect in the Global pharmaceutical landscape, raising alarms about potential repercussions for India's
Kuala Lumpur [Malaysia], May 2: As Southeast Asia's pharmaceutical industry rapidly evolves--driven by regulatory harmonization, innovation, and growing healthcare demand--CPHI South East Asia 2025 provides a vital platform to connect with regional stakeholders, showcase breakthroughs, and u
The 9th edition of the Global Pharmaceutical Quality Summit which brought together experts, industry leaders, and stakeholders among others to foster knowledge exchange and deliberate on areas of importance in shaping the pharmaceutical landscape in India took place here on Thursday.